This provider's $6.1M in total Medicare payments ranks in the 84th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2023 | $430.57 | $397.78 | 1.08x | $32.79 | $6.1M | 15.3K | 21 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 424 | $758.3K | $1.8K | 1.09x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 988 | $655.0K | $662.97 | 1.12x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 998 | $627.8K | $629.01 | 1.12x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 913 | $605.3K | $662.97 | 1.12x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 829 | $487.5K | $588.00 | 1.02x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 800 | $470.4K | $588.00 | 1.02x |
| 81222 | Gene analysis (cystic fibrosis transmembrane conductance regular) duplication or deletion variants | 1.0K | $428.9K | $426.37 | 1.02x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 831 | $406.4K | $489.02 | 1.02x |
| 81300 | Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants | 1.1K | $266.6K | $233.24 | 1.12x |
| 81319 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) duplication or deletion variants | 1.1K | $227.7K | $199.43 | 1.12x |
| 81292 | Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis | 279 | $184.7K | $661.89 | 1.09x |
| 81279 | Gene analysis (janus kinase 2) targeted sequence analysis | 1.0K | $183.0K | $181.50 | 1.02x |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 1.0K | $183.0K | $181.50 | 1.02x |
| 81295 | Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis | 472 | $176.6K | $374.07 | 1.09x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 233 | $137.0K | $588.00 | 1.10x |
| 81323 | Gene analysis (phosphatase and tensin homolog), duplication or deletion variant | 245 | $72.0K | $294.00 | 1.10x |
| 81294 | Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) duplication or deletion variants | 283 | $56.1K | $198.35 | 1.10x |
| 81250 | Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants | 852 | $48.8K | $57.32 | 1.02x |
| 81297 | Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants | 181 | $37.8K | $209.03 | 2.10x |
| 81209 | Gene analysis (bloom syndrome, recq helicase-like) | 818 | $31.5K | $38.52 | 1.02x |
This provider submits charges 1.08 times higher than what Medicare actually pays.
A markup ratio of 1.08x means for every $100 Medicare pays, this provider initially charges $108. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Raritan, NJ | $1.2B | ⚠️ Flagged |
| Quest Diagnostics Incorporated | Clifton, NJ | $927.2M | ⚠️ Flagged |
| Bioreference Health, Llc | Elmwood Park, NJ | $841.0M | ⚠️ Flagged |
| Accu Reference Medical Lab, Llc | Linden, NJ | $204.9M | ⚠️ Flagged |
| Aculabs Inc | East Brunswick, NJ | $91.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data